ARR Fundamental Analysis - ARRIBATEC GROUP ASA

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to ARR. ARR was compared to 73 industry peers in the IT Services industry. Both the profitability and financial health of ARR have multiple concerns. ARR is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ARR had negative earnings in the past year.

ARR had a positive operating cash flow in the past year.

ARR had negative earnings in each of the past 5 years.

In multiple years ARR reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of ARR (-5.38%) is worse than 78.08% of its industry peers.

With a Return On Equity value of -8.98%, ARR is not doing good in the industry: 72.60% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-5.38%
ROE	-8.98%
ROIC	N/A

ROA(3y)-13.16%

ROA(5y)-12.37%

ROE(3y)-27.36%

ROE(5y)-23.02%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ARR has a better Gross Margin (74.44%) than 61.64% of its industry peers.

ARR's Gross Margin has improved in the last couple of years.

ARR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	74.44%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.35%

GM growth 5Y15.65%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ARR does not have a ROIC to compare to the WACC, probably because it is not profitable.

ARR has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, ARR has more shares outstanding

The debt/assets ratio for ARR is higher compared to a year ago.

2.2 Solvency

ARR has a debt to FCF ratio of 5.43. This is a neutral value as ARR would need 5.43 years to pay back of all of its debts.

ARR has a Debt to FCF ratio (5.43) which is comparable to the rest of the industry.

ARR has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.

ARR's Debt to Equity ratio of 0.06 is amongst the best of the industry. ARR outperforms 87.67% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.06
Debt/FCF	5.43
Altman-Z	N/A

ROIC/WACCN/A

WACC7.76%

2.3 Liquidity

ARR has a Current Ratio of 1.16. This is a normal value and indicates that ARR is financially healthy and should not expect problems in meeting its short term obligations.

ARR has a Current ratio (1.16) which is in line with its industry peers.

ARR has a Quick Ratio of 1.12. This is a normal value and indicates that ARR is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 1.12, ARR is in line with its industry, outperforming 50.68% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.16
Quick Ratio	1.12

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ARR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -404.00%.

ARR shows a decrease in Revenue. In the last year, the revenue decreased by -0.03%.

The Revenue has been growing by 131.41% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-404%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%136.21%

Revenue 1Y (TTM)-0.03%

Revenue growth 3Y11.56%

Revenue growth 5Y131.41%

Sales Q2Q%-4.8%

3.2 Future

The Earnings Per Share is expected to grow by 39.32% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 11.45% on average over the next years. This is quite good.

EPS Next Y91.36%

EPS Next 2Y39.32%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year11.05%

Revenue Next 2Y11.45%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ARR. In the last year negative earnings were reported.

Also next year ARR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ARR indicates a slightly more expensive valuation: ARR is more expensive than 73.97% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	107.96
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ARR's earnings are expected to grow with 39.32% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y39.32%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ARR!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

ARRIBATEC GROUP ASA

OSL:ARR (1/9/2026, 7:00:00 PM)

0 (0%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustryIT Services

Earnings (Last)10-30 2025-10-30

Earnings (Next)02-27 2026-02-27

Inst Owners0.1%

Inst Owner ChangeN/A

Ins Owners13.64%

Ins Owner ChangeN/A

Market Cap534.96M

Revenue(TTM)569.28M

Net Income(TTM)-23.85M

Analysts80

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.94
P/FCF	107.96
P/OCF	48.42
P/B	2.02
P/tB	9.32
EV/EBITDA	N/A

EPS(TTM)-6.25

EYN/A

EPS(NY)-0.03

Fwd EYN/A

FCF(TTM)0.07

FCFY0.93%

OCF(TTM)0.17

OCFY2.07%

SpS8.51

BVpS3.97

TBVpS0.86

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-5.38%
ROE	-8.98%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	74.44%
FCFM	0.87%

ROA(3y)-13.16%

ROA(5y)-12.37%

ROE(3y)-27.36%

ROE(5y)-23.02%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.35%

GM growth 5Y15.65%

F-Score6

Asset Turnover1.28

Health

		Industry Rank	Sector Rank
Debt/Equity	0.06
Debt/FCF	5.43
Debt/EBITDA	N/A
Cap/Depr	14.36%
Cap/Sales	1.07%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.16
Quick Ratio	1.12
Altman-Z	N/A

F-Score6

WACC7.76%

ROIC/WACCN/A

Cap/Depr(3y)30.71%

Cap/Depr(5y)67.66%

Cap/Sales(3y)2.72%

Cap/Sales(5y)4.66%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-404%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%136.21%

EPS Next Y91.36%

EPS Next 2Y39.32%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-0.03%

Revenue growth 3Y11.56%

Revenue growth 5Y131.41%

Sales Q2Q%-4.8%

Revenue Next Year11.05%

Revenue Next 2Y11.45%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-45.24%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year314.29%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y33.85%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y14.51%

OCF growth 3YN/A

OCF growth 5YN/A

ARRIBATEC GROUP ASA / ARR.OL FAQ

What is the fundamental rating for ARR stock?

ChartMill assigns a fundamental rating of 3 / 10 to ARR.OL.

What is the valuation status of ARRIBATEC GROUP ASA (ARR.OL) stock?

ChartMill assigns a valuation rating of 1 / 10 to ARRIBATEC GROUP ASA (ARR.OL). This can be considered as Overvalued.

Can you provide the profitability details for ARRIBATEC GROUP ASA?

ARRIBATEC GROUP ASA (ARR.OL) has a profitability rating of 2 / 10.

How financially healthy is ARRIBATEC GROUP ASA?

The financial health rating of ARRIBATEC GROUP ASA (ARR.OL) is 3 / 10.

ARRIBATEC GROUP ASA (ARR.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

ARRIBATEC GROUP ASA / ARR.OL FAQ

What is the fundamental rating for ARR stock?

What is the valuation status of ARRIBATEC GROUP ASA (ARR.OL) stock?

Can you provide the profitability details for ARRIBATEC GROUP ASA?

How financially healthy is ARRIBATEC GROUP ASA?